Dr. Pailla Malla Reddy

President and CEO

Dr. Pailla Malla Reddy began his career 23 years ago working in various positions for leading pharmaceutical companies in Lagos, Nigeria, India and USA. Dr Reddy founded Sciegen Pharmaceuticals Inc. in 2009. Sciegen operates a facility in Hauppuage, NY. Dr Reddy has successfully launched and actively manages other leading pharmaceutical companies in the USA and other countries as a Director. He also founded Bactolac Pharmaceutical, Inc. in 1995 and has grown the company exponentially over the years. He also operates other companies in Russia. Dr. Reddy holds a Ph.D in Chemistry from Kanpur University in India.

Renee Reynolds

Vice President, Chief Financial Officer

Ms. Reynolds has served as Chief Financial Officer since Sciegen was founded in September 2009. She is also currently the CFO for Bactolac Pharmaceutical Inc on Long Island since May 2006. Prior to this, Ms. Reynolds has served as Corporate Controller and Chief Financial Officer for Direct Marketing and Media companies for the last 20 years. Ms. Reynolds also has served as CEO of her own financial consulting company, Reynolds Financial Solutions. At the start of her career, Ms. Reynolds had spent several years in public accounting with KPMG on Long Island at which point she became a certified public accountant in the state of New York and is a member of the AICPA. Ms. Reynolds graduated cum laude from Hofstra University with a BBA degree in Accounting in 1982.

Mr. Siva Reddy PV

Vice President, Director of Formulation

Mr. Reddy brings over 16 years of experience in the pharmaceutical industry in the areas of analytical research and development, pre-formulations, new product development and regulatory submissions. Before joining Sciegen, Mr. Reddy served as Associate Vice President with Aurobindo Pharma Limited in India overseeing the research center in handling all kinds of sterile formulations. He has significant experience in Solid Oral dosages, liquids and Parenterals. Mr. Reddy has also spent over 12 years with Dr Reddy’s Laboratories Limited, India as the Associate Director of New Product Development in their Generic Pharmaceutical division. Mr. Reddy is responsible for almost 100 ANDA, NDA, EU drug filings throughout the USA, Canada and Europe and has several patents ( US and WO) and has written several publications prior to joining Sciegen. He holds an MS degree in Pharmacy from Dr MGR Medical University in India.

Dr. P. Raghu Ram

Head, Quality Assurance and Regulatory Affairs

P. Raghu Ram holds a Ph.D in Analytical Chemistry from Sri Krishnadevaraya University in India and has over 18 years of experience in the pharmaceutical industry in the areas of Analytical, Quality and Regulatory Compliance. He holds such distinctions as a CQA [Certified Quality Auditor] and CMQ/OE [Certified manager for Organizational Excellence] from ASQ [American Society for Quality]. P. Raghu Ram is also a member of IPC [Indian Pharmacopeial Commission] and USP [United States Pharmacopeia] 2005-2010 monographs acquisition committee. Mr. Ram had published 18 research publications during his career.

Krishna Mohan Chilakamarthy

Associate Director, Quality Control

Krishna brings over 18 years of experience in the pharmaceutical industry in the areas of Quality Control and Analytical development. He holds Masters Degree in Chemistry from Andhra University, India. Before joining ScieGen Pharmaceuticals Inc, Krishna worked at Halo Pharmaceuticals, NJ based CRO & CDMO for about 4 years taking care of Analytical Development & Analytical Services activities for various projects for different customers. Prior to joining Halo, Krishna worked in Dr Reddy’s Laboratories Limited, India for about 8 years, and at Par Pharmaceuticals, USA for about 5 years and handled different responsibilities at various positions.